RE: p53 PROTEIN AND GENE ALTERATIONS IN PATHOLOGICAL STAGE C PROSTATE CARCINOMA (1998)

No AccessJournal of UrologyClinical Urology: Letters to the Editor1 May 1998RE: p53 PROTEIN AND GENE ALTERATIONS IN PATHOLOGICAL STAGE C PROSTATE CARCINOMA C.E. Salem, N.A. Tomasic, D.A. Elmajian, D. Esrig, P.W. Nichols, C.R. Taylor, D.G. Skinner, P. Roy-Burman, G. Lieskovsky, and R.J. Cote C.E. SalemC.E. Salem More articles by this author , N.A. TomasicN.A. Tomasic More articles by this author , D.A. ElmajianD.A. Elmajian More articles by this author , D. EsrigD. Esrig More articles by this author , P.W. NicholsP.W. Nichols More articles by this author , C.R. TaylorC.R. Taylor More articles by this author , D.G. SkinnerD.G. Skinner More articles by this author , P. Roy-BurmanP. Roy-Burman More articles by this author , G. LieskovskyG. Lieskovsky More articles by this author , and R.J. CoteR.J. Cote More articles by this author View All Author Informationhttps://doi.org/10.1097/00005392-199805000-00078AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "RE: p53 PROTEIN AND GENE ALTERATIONS IN PATHOLOGICAL STAGE C PROSTATE CARCINOMA." The Journal of Urology, 159(5), pp. 1648–1649 References 1 : p53 Nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Amer. J. Path.1993; 143: 1389. Google Scholar 2 : Accumulation of nuclear p53 and tumor progression in bladder cancer. New Engl. J. Med.1994; 331: 1259. Google Scholar 3 : p53 Mutations occur in clinical, but not latent, human prostate carcinoma. Jap. J. Cancer Res.1995; 86: 57. Google Scholar 4 : p53 Is mutated in a subset of advanced-stage prostate cancers. Cancer Res.1993; 53: 3369. Google Scholar 5 : p53 Accumulation and gene mutation in the progression of human prostate carcinoma. J. Natl. Cancer Inst.1993; 85: 1657. Google Scholar 6 : p53 Status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610. J. Natl. Cancer Inst.1997; 89: 158. Google Scholar 7 : Small subgroup of aggressive, highly proliferative prostatic carcinomas defined by p53 accumulation. J. Natl. Cancer Inst.1992; 84: 883. Google Scholar 8 : Immunohistochemical determination of p53 protein nuclear accumulation in prostatic adenocarcinoma. J. Urol.1994; 151: 1276. Abstract, Google Scholar 9 : p53 and Ki-67 immunoreactivity in human prostate cancer and benign hyperplasia. Brit. J. Urol.1992; 69: 609. Google Scholar 10 : Heterogeneity in intratumor distribution of p53 mutations in human prostate cancer. Amer. J. Path.1995; 147: 92. Google Scholar 11 : p53 Mutations in human bladder cancer: genotype versus phenotypic patterns. Int. J. Cancer.1994; 56: 347. Google Scholar © 1998 by American Urological Association, Inc.FiguresReferencesRelatedDetails Volume 159Issue 5May 1998Page: 1648-1649 Advertisement Copyright & Permissions© 1998 by American Urological Association, Inc.MetricsAuthor Information C.E. Salem More articles by this author N.A. Tomasic More articles by this author D.A. Elmajian More articles by this author D. Esrig More articles by this author P.W. Nichols More articles by this author C.R. Taylor More articles by this author D.G. Skinner More articles by this author P. Roy-Burman More articles by this author G. Lieskovsky More articles by this author R.J. Cote More articles by this author Expand All Advertisement Loading ...